StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
FibroGen (FGEN) to Resume Trading at 2:30 pm
November 8, 2019 2:12 PM
FibroGen (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trading Halts
Next Articles
FibroGen (FGEN) Misses Q3 EPS by 2c, Revenues Miss
November 11, 2019 4:04 PM
FibroGen (FGEN) Reports Positive Phase 3 Pooled Roxadustat Safety & Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
November 8, 2019 3:00 PM
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
November 8, 2019 2:10 PM
AstraZeneca (AZN) and FibroGen Inc. (FGEN) Roxadustat Phase III Program Pooled Analyses Showed Positive Efficacy and No Increased Cardiovascular Risk in Patients with Anemia from Chronic Kidney Diseas
November 8, 2019 2:09 PM
FibroGen (FGEN) Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
November 8, 2019 2:03 PM
Form 8-K FIBROGEN INC For: Nov 08
November 8, 2019 2:01 PM
FibroGen (FGEN) halted, news pending
November 8, 2019 1:56 PM
